Eton Pharmaceuticals Submits New Drug Application to the FDA for Orphan Drug Dehydrated Alcohol Injection (DS-100)
-Granted Orphan Drug Designation by the FDA for the Treatment of Methanol Poisoning-Since the Start of COVID-19, the FDA has […]
AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets
Vyleesi® returned to Palatin TechnologiesCompany focuses on optimizing marketed assets and development of its innovative pipelineWALTHAM, Mass., July 27, 2020 […]
Lincoln Electric Reports Second Quarter 2020 Results
Second Quarter 2020 HighlightsNet sales decline 24.0% on lower organic salesOperating income margin of 6.7%; Adjusted operating income margin of […]
Cowen Cross-Asset Team Announces Six Key Hires, Continuing Expansion
NEW YORK, July 27, 2020 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced six key recent […]
Harrow Health to Announce Second Quarter 2020 Financial Results on August 10, 2020
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of […]
Internationally Renowned High Tech, Quantitative Marketing and Digital Economy Expert Anindya Ghose Affiliates with Compass Lexecon
WASHINGTON, July 27, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Professor Anindya Ghose, the Heinz […]
Clearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting
ALPHARETTA, Ga., July 27, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments […]
AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2020
Company reports EPS of $0.65, Economic EPS of $2.74 in second quarter of 2020Net Income (controlling interest) of $31 million, […]
Athenex, Inc. to Report Second Quarter 2020 Earnings Results on August 6, 2020
BUFFALO, N.Y., July 27, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, […]
RedHill Biopharma Increases Patient Access to Talicia® with EnvisionRx Formularies
Talicia® is the first and only FDA-approved rifabutin-based therapy for H. pylori infection designed as a first-line option to address […]
